p63 is a tumour suppressor protein that is very similar to p53 in structure and function, while being homologous to p73. p63 is important in development and differentiation, and has been identified as a useful marker for distinguishing between lung squamous cell carcinomas and adenocarcinomas. Anti-p63 is also used to differentiate between benign and malignant prostate and breast lesions, due to its labeling of the nuclei of myoepithelial cells in both tissue types.

• IHC063-p63 Datasheet-IVD

• MSDS
• GeneAb™ IHC Antibodies ranked Optimal by NordiQC
• 2021 NordiQC Assessment Report for IHC063: Good

CLONE:
IHC063

ISOTYPE:
IgG1

HOST SPECIES:
Mouse

CLONALITY:
Monoclonal

POSITIVE CONTROL:
Skin, Squamous Cell Carcinoma, Prostate

DILUTION RANGE:


INTENDED USE/REG. STATUS:
IVD

ADDITIONAL INFORMATION:
NordiQC Rating: Good
(Assessment Run 61 2021)